Co-mutated pathways analysis highlights the coordination mechanism in glioblastoma multiforme.

@article{Wei2014ComutatedPA,
  title={Co-mutated pathways analysis highlights the coordination mechanism in glioblastoma multiforme.},
  author={Bo Wei and L. Wang and X D Zhao and Y. L. Jin and Daliang Kong and Guozhang Hu and Z. Sun},
  journal={Neoplasma},
  year={2014},
  volume={61 4},
  pages={
          424-32
        }
}
The mutation of cancer represents a high heterogeneity characteristic, setting a big obstacle in the mechanism study of it. In this study, we explored the distributions of mutated genes in pathways in glioblastoma multiforme (GBM), and constructed networks of co-mutated pathway pairs under the false discovery rate (FDR) control. By comparing the mutation frequencies, a total of 50 mutated genes were screened with the frequency > 3, and TP53, PTEN, and EGFR were the top 3 genes. By KEGG… 
4 Citations

Figures and Tables from this paper

Transcriptomics Evidence for Common Pathways in Human Major Depressive Disorder and Glioblastoma
TLDR
This article relies on transcriptome data to obtain reliable and useful differentially expressed genes (DEGs) by differential expression analysis, and uses the transcriptomics of DEGs to find out and analyze the common pathway of MDD and GBM from three directions.
PIPs in neurological diseases.
  • M. Waugh
  • Biology
    Biochimica et biophysica acta
  • 2015
A 5‐gene prognostic nomogram predicting survival probability of glioblastoma patients
TLDR
Predicting the survival probability for GBM patients newly diagnosed in clinical practice is meaningful to predict the overall survival of each GBM patient.

References

SHOWING 1-10 OF 45 REFERENCES
Analysis of pathway mutation profiles highlights collaboration between cancer‐associated superpathways
TLDR
The hypothesis that comprehensive cooperation among a few basic functions is required for inducing cancer is supported, and biologically plausible models for understanding the heterogeneous mechanisms of cancers are suggested.
Identification of rare cancer driver mutations by network reconstruction.
TLDR
This work modified and applied a network reconstruction and coexpression module identification-based approach to identify functionally related gene modules targeted by somatic mutations in cancer, and identified Wnt/TGF-beta cross-talk,Wnt/VEGF signaling, and MAPK/focal adhesion kinase pathways as targets of rare driver mutations in breast, colorectal cancer,and glioblastoma, respectively.
Somatic mutations affect key pathways in lung adenocarcinoma
TLDR
Somatic mutations in primary lung adenocarcinoma for several tumour suppressor genes involved in other cancers and for sequence changes in PTPRD as well as the frequently deleted gene LRP1B are found.
Screening Key Genes and Pathways in Glioma Based on Gene Set Enrichment Analysis and Meta-analysis
TLDR
The gene pathways that the authors identified could provide insight concerning the development of glioma and further studies are needed to determine the biological function for the positive genes.
Finding co-mutated genes and candidate cancer genes in cancer genomes by stratified false discovery rate control.
TLDR
A stratified FDR (False Discovery Rate) control approach for identifying significantly co-mutated gene pairs according to the mutation frequency of genes is proposed and it is demonstrated that, at a given FDR level, the power of finding co- mutant gene pairs could be increased by pre-selecting genes with higher mutation frequencies, however, many true co-mutation between genes with lower mutation rates will still be missed.
Core Signaling Pathways in Human Pancreatic Cancers Revealed by Global Genomic Analyses
TLDR
It is found that pancreatic cancers contain an average of 63 genetic alterations, the majority of which are point mutations, which defined a core set of 12 cellular signaling pathways and processes that were each genetically altered in 67 to 100% of the tumors.
Cell cycle and aging, morphogenesis, and response to stimuli genes are individualized biomarkers of glioblastoma progression and survival
TLDR
The identified biomarkers support the development of more accurate and personalized prognostic tools and gene-based therapies that improve the survival and quality of life of individuals afflicted by glioblastoma multiforme.
Combinatorial patterns of somatic gene mutations in cancer
  • C. Yeang, F. McCormick, A. Levine
  • Biology
    FASEB journal : official publication of the Federation of American Societies for Experimental Biology
  • 2008
TLDR
The observed mutational patterns suggest candidates of new cosequencing targets that can either reveal novel patterns or validate the predictions deduced from existing patterns, and provide guiding information for the ongoing cancer genome projects.
Glioblastoma Multiforme Oncogenomics and Signaling Pathways
TLDR
The current understanding of GBM oncogenomics, signaling pathways, and glioma stem cell biology is provided and the potential new therapeutic targets on the horizon are discussed.
Identification of Networks of Co-Occurring, Tumor-Related DNA Copy Number Changes Using a Genome-Wide Scoring Approach
TLDR
The findings suggest that large-scale, low-intensity copy number alterations may be an important feature of cancer development or maintenance by affecting gene dosage of a large interconnected network of functionally related genes.
...
...